{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T07:02:28Z","timestamp":1780038148244,"version":"3.53.1"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Haploidentical peripheral blood hematopoietic stem cell transplantation (haploPBSCT) is increasingly performed for both malignant and nonmalignant diseases. This study evaluated the outcomes of critically ill patients after haploPBSCT who were admitted to the pediatric intensive care unit (PICU).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This single-center, retrospective study included pediatric patients who underwent haploPBSCT (\n                      <jats:italic>ex vivo<\/jats:italic>\n                      \u03b1\u03b2+ T-cell and CD19+ B-cell depleted after 2012) and were admitted to the PICU between 2010 and 2023. Data were collected from electronic medical records. The primary outcomes were 30-day mortality from the time of PICU admission and in-hospital mortality. Secondary analyses examined risk factors associated with these outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 63 patients met the inclusion criteria. The 30-day and in-hospital mortality rates were 33.3% and 50.8%, respectively. The most common reason for PICU admission was respiratory complications. In multivariate logistic regression analysis, chronic graft-vs.-host-disease was independently associated with 30-day mortality [\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.043, odds ratio (OR) 4.515; 95% confidence interval (CI): 1.050\u201319.414], while ventilator use was an independent predictor of in-hospital mortality [\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.046, OR 5.15 (95% CI: 1.029\u201325.724)]. Among patients who survived beyond 30 days in the PICU, 11 subsequently died, 10 of whom had received ventilator support for respiratory failure; pneumonia was the most common cause of death.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Thirty-day and in-hospital mortality rates after haploPBSCT were comparable to those reported for allogenic PBSCT. Most critically ill pediatric patients required PICU admission for respiratory complications. Ventilator use independently predicted in-hospital mortality, underscoring the importance of early detection and prevention of respiratory failure following haploPBSCT.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2026.1782412","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T06:10:33Z","timestamp":1780035033000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Outcomes of critically ill pediatric patients after haploidentical stem cell transplantation"],"prefix":"10.3389","volume":"14","author":[{"given":"Da Hyun","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Asan Medical Center Children\u2019s Hospital, University of Ulsan College of Medicine","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Joon","family":"Im","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology\u2013Oncology, Department of Pediatrics, Asan Medical Center Children\u2019s Hospital, University of Ulsan College of Medicine","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Kyoung","family":"Jhang","sequence":"additional","affiliation":[{"name":"Division of Pediatric Critical Care Medicine, Department of Pediatrics, Asan Medical Center Children\u2019s Hospital, University of Ulsan College of Medicine","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Han","family":"Kang","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology\u2013Oncology, Department of Pediatrics, Asan Medical Center Children\u2019s Hospital, University of Ulsan College of Medicine","place":["Seoul, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1037.e1","DOI":"10.1016\/j.jtct.2025.09.014","article-title":"Haploidentical vs. Matched sibling donor HCT in racially diverse pediatric and AYA patients with hematologic malignancies: a single-center comparison","volume":"31","author":"Filioglou","year":"2025","journal-title":"Transplant Cell Ther"},{"key":"B2","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/s41409-019-0610-5","article-title":"Haploidentical stem cell transplantation (HaploSCT) for patients with acute leukemia-an update on behalf of the ALWP of the EBMT","volume":"54","author":"Nagler","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"B3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/sj.bmt.1705963","article-title":"Searching for alternative hematopoietic stem cell donors for pediatric patients","volume":"41","author":"Rocha","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"B4","doi-asserted-by":"publisher","first-page":"72","DOI":"10.4103\/hemoncstem.HEMONCSTEM-D-24-00037","article-title":"Outcomes of matched sibling and haploidentical donors hematopoietic stem cell transplantation for pediatric severe aplastic Anemia: a retrospective multicenter study","volume":"18","author":"Valencia","year":"2025","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"B5","doi-asserted-by":"publisher","first-page":"245.e1","DOI":"10.1016\/j.jtct.2023.11.012","article-title":"Comparison of stem cell transplantation using unrelated, haploidentical, and sibling donors for patients with acquired severe aplastic Anemia: a single-center retrospective cohort study","volume":"30","author":"Fu","year":"2024","journal-title":"Transplant Cell Ther"},{"key":"B6","doi-asserted-by":"publisher","first-page":"837335","DOI":"10.3389\/fimmu.2022.837335","article-title":"Comparison of hematopoietic stem cell transplantation outcomes using matched sibling donors, haploidentical donors, and immunosuppressive therapy for patients with acquired aplastic Anemia","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e13810","DOI":"10.1111\/ctr.13810","article-title":"Comparable survival outcome between transplantation from haploidentical donor and matched related donor or unrelated donor for severe aplastic anemia patients aged 40 years and older: a retrospective multicenter cohort study","volume":"34","author":"Zhang","year":"2020","journal-title":"Clin Transplant"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1007\/s00277-024-05737-5","article-title":"Comparable outcomes of allogeneic peripheral blood versus bone marrow hematopoietic stem cell transplantation from a sibling donor for pediatric patients","volume":"103","author":"Kim","year":"2024","journal-title":"Ann Hematol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e70012","DOI":"10.1002\/jha2.70012","article-title":"Haploidentical allogeneic stem cell transplantation as a superior alternative for patients with mismatch donors-A single center experience in 152 patients","volume":"6","author":"J\u00e4ger","year":"2025","journal-title":"EJHaem"},{"key":"B10","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s00277-020-04383-x","article-title":"Haploidentical hematopoietic stem cell transplantation for patients with myeloid sarcoma: a single center retrospective study","volume":"100","author":"Yu","year":"2021","journal-title":"Ann Hematol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e31390","DOI":"10.1002\/pbc.31390","article-title":"Successful haploidentical allogeneic stem cell transplantation for a pediatric chronic neutrophilic leukemia","volume":"72","author":"Luo","year":"2025","journal-title":"Pediatr Blood Cancer"},{"key":"B12","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1055\/s-2006-942256","article-title":"Haploidentical stem cell transplantation in patients with pediatric solid tumors: preliminary results of a pilot study and analysis of graft versus tumor effects","volume":"218","author":"Lang","year":"2006","journal-title":"Klin Padiatr"},{"key":"B13","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3892\/etm.2024.12457","article-title":"Risk factors and predictive model for mortality in patients undergoing allogeneic hematopoietic stem cell transplantation admitted to the intensive care unit","volume":"27","author":"Wu","year":"2024","journal-title":"Exp Ther Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/bmt.2010.255","article-title":"Outcome in critically ill patients with allogeneic BM or peripheral haematopoietic SCT: a single-centre experience","volume":"46","author":"Depuydt","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1164\/rccm.202401-0135OC","article-title":"Outcomes in critically ill allogeneic hematopoietic stem-cell transplantation recipients","volume":"210","author":"Lafarge","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1182\/bloodadvances.2020002444","article-title":"\u03b1\u03b2 T-cell graft depletion for allogeneic HSCT in adults with hematological malignancies","volume":"5","author":"de Witte","year":"2021","journal-title":"Blood Adv"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.jcyt.2025.07.005","article-title":"Very early recovery of T cells after alpha\/beta T cell-depleted haploidentical HSCT predicts the outcome in children with leukemia","volume":"27","author":"Glushkova","year":"2025","journal-title":"Cytotherapy"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2025.12.999","article-title":"Incidence and impact of endothelial dysfunction events and veno-occlusive disease in haploidentical stem cell transplantation with post-transplant cyclophosphamide: a retrospective analysis from the argentinian group of marrow transplant and cellular therapy (GATMO-TC)","author":"Bentolila","year":"2026","journal-title":"Transplant Cell Ther"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e70003","DOI":"10.1111\/petr.70003","article-title":"A second Look: retrospective identification of thrombotic microangiopathy in pediatric stem cell transplant patients with veno-occlusive disease","volume":"29","author":"Rahim","year":"2025","journal-title":"Pediatr Transplant"},{"key":"B20","doi-asserted-by":"publisher","first-page":"914.e1","DOI":"10.1016\/j.jtct.2024.06.003","article-title":"Sinusoidal obstruction syndrome\/veno-occlusive disease after unmanipulated haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide: a study on behalf of the Spanish hematopoietic stem cell transplantation and cellular therapy group (GETH)","volume":"30","author":"G\u00f3mez-Centuri\u00f3n","year":"2024","journal-title":"Transplant Cell Ther"},{"key":"B21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.bbmt.2009.08.024","article-title":"Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome","volume":"16","author":"Coppell","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"B22","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/bmt.2017.161","article-title":"Diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation","volume":"53","author":"Corbacioglu","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"B23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3390\/biomedicines5030035","article-title":"Role of alphabeta T cell depletion in prevention of graft versus host disease","volume":"5","author":"Abdelhakim","year":"2017","journal-title":"Biomedicines"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e2016057","DOI":"10.4084\/mjhid.2016.057","article-title":"Immunity to infections after haploidentical hematopoietic stem cell transplantation","volume":"8","author":"Aversa","year":"2016","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41409-021-01551-z","article-title":"Results of a multicenter phase I\/II trial of TCRalphabeta and CD19-depleted haploidentical hematopoietic stem cell transplantation for adult and pediatric patients","volume":"57","author":"Bethge","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"B26","doi-asserted-by":"publisher","first-page":"4278","DOI":"10.1182\/bloodadvances.2021004941","article-title":"Nonrelapse mortality among patients diagnosed with chronic GVHD: an updated analysis from the chronic GVHD consortium","volume":"5","author":"DeFilipp","year":"2021","journal-title":"Blood Adv"},{"key":"B27","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1097\/TP.0b013e3181cee42f","article-title":"International consensus guidelines on the management of cytomegalovirus in solid organ transplantation","volume":"89","author":"Kotton","year":"2010","journal-title":"Transplantation"},{"key":"B28","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.jtct.2021.05.001","article-title":"American Society for transplantation and cellular therapy series: #3-prevention of cytomegalovirus infection and disease after hematopoietic cell transplantation","volume":"27","author":"Hakki","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"B29","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1093\/jpids\/piad059","article-title":"Current and emerging antiviral agents in the prevention and treatment of cytomegalovirus in pediatric transplant recipients","volume":"13","author":"Valencia Deray","year":"2024","journal-title":"J Pediatric Infect Dis Soc"},{"key":"B30","doi-asserted-by":"publisher","first-page":"478.e1","DOI":"10.1016\/j.jtct.2021.03.010","article-title":"Feasibility and efficacy of CD45RA+ depleted donor lymphocytes infusion after haploidentical transplantation with post-transplantation cyclophosphamide in patients with hematological malignancies","volume":"27","author":"Castagna","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"B31","doi-asserted-by":"publisher","first-page":"10.1111\/tid.12823","DOI":"10.1111\/tid.12823","article-title":"Selective T-cell depletion targeting CD45RA reduces viremia and enhances early T-cell recovery compared with CD3-targeted T-cell depletion","volume":"20","author":"Triplett","year":"2018","journal-title":"Transpl Infect Dis"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1007\/s00277-021-04640-7","article-title":"Outcome of allogeneic hematopoietic stem cell transplant recipients admitted to the intensive care unit with a focus on haploidentical graft and sequential conditioning regimen: results of a retrospective study","volume":"100","author":"Gournay","year":"2021","journal-title":"Ann Hematol"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1782412\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T06:10:34Z","timestamp":1780035034000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1782412\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":32,"alternative-id":["10.3389\/fped.2026.1782412"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1782412","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"article-number":"1782412"}}